New Horizon seals high price for $263m HK IPO

Jonathan Breen

February 11, 2021 06:15 am

Healthcare medical biopharmaceutical investing stock chart background | Kurhan - stock.adobe.com

New Horizon Health, a medical device manufacturer, has scooped up HK$2.04bn ($263.4m) from its IPO after strong institutional investor demand pushed pricing up to the top of the marketed range.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOs UBS Equity China Hong Kong SAR Asia Greater China Haitong Securities Northeast Asia Asia Pacific Emerging Markets Goldman Sachs Daiwa Securities

JB

Jonathan Breen

Equities editor GlobalCapital Asia